{"id":21245,"date":"2024-11-04T10:44:25","date_gmt":"2024-11-04T10:44:25","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/"},"modified":"2024-11-04T11:01:32","modified_gmt":"2024-11-04T11:01:32","slug":"nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/","title":{"rendered":"New Guidelines for Sterile Production According to EU GMP Annex 1"},"content":{"rendered":"

The Annex 1 introduces new guidelines for equipment and utility systems in pharmaceutical sterile production.<\/strong> These guidelines focus on specific requirements, particularly those under increased regulatory scrutiny, to ensure that all Critical Control Points<\/strong> (CCP) and Critical Process Parameters<\/strong> (CPP) are fully managed and documented.<\/p>\n

System Impact Assessment<\/h2>\n

A key aspect of the new guidelines is the need for an accurate system impact assessment, which includes:<\/p>\n

    \n
  • Accurate and live documentation<\/strong>: This must be updated in real-time to reflect any changes or updates in the system.<\/li>\n
  • Critical alarm assessment<\/strong>: Identification and rigorous testing of critical alarms are essential to prevent undesired batch progressions. The absence of critical alarms could compromise product safety.<\/li>\n<\/ul>\n

    Management of Direct and Indirect Product Contact Parts<\/h3>\n

    Annex 1 provides greater clarity on the sterilization of indirect product contact parts<\/strong>. It is crucial to ensure that all parts indirectly in contact with the product are adequately sterilized to prevent contamination.<\/p>\n

    Monitoring and Calibration of Particle Counters<\/h3>\n

    The updated ISO14644<\/strong> standards require more detailed monitoring of non-viable particles. This implies that the placement and maintenance of particle counters must comply with standards to avoid unwanted contamination during the production process.<\/p>\n

    Requirements for Purified Water Systems<\/h3>\n

    To ensure the quality of water used in sterile production, Annex 1 recommends:<\/p>\n

      \n
    • Continuous flow monitoring<\/strong>: To ensure turbulent flow, considered a CPP.<\/li>\n
    • Distillation as the preferred method<\/strong>: For the production of Water for Injection (WFI), although other methods may be acceptable with appropriate justification.<\/li>\n
    • Design to minimize microbial and endotoxin contamination risks<\/strong>: Optimizing elements such as line slopes and reducing dead legs.<\/li>\n<\/ul>\n

      Steam Quality and Heat Exchanger Testing<\/h3>\n

      The standard for steam used in sterile processes requires particular attention to its physical parameters, including humidity and superheat. Heat exchangers, especially those in the cooling zone of sterilization tunnels, must be designed and monitored to prevent leaks and ensure adequate sterilization.<\/p>\n

      Conclusions<\/h3>\n

      The new Annex 1 introduces detailed requirements for the management and qualification of equipment and utilities in sterile environments<\/strong>r. Compliance with these guidelines requires rigorous documentation management and continuous risk assessment.<\/p>\n","protected":false},"excerpt":{"rendered":"

      Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central is the evaluation of the impact of the system, in addition to the sterilization of parts in indirect contact and compliance with ISO regulations for particles, as well as rigorous management and continuous risk assessment.<\/p>\n","protected":false},"author":32,"featured_media":21243,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[810,845],"tags":[],"class_list":{"0":"post-21245","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-gmp-en","8":"category-quality"},"yoast_head":"\nNew Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-04T10:44:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T11:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0\"},\"headline\":\"New Guidelines for Sterile Production According to EU GMP Annex 1\",\"datePublished\":\"2024-11-04T10:44:25+00:00\",\"dateModified\":\"2024-11-04T11:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\"},\"wordCount\":345,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg\",\"articleSection\":[\"GMP\",\"Quality & Validation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\",\"name\":\"New Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg\",\"datePublished\":\"2024-11-04T10:44:25+00:00\",\"dateModified\":\"2024-11-04T11:01:32+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0\"},\"description\":\"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg\",\"width\":2560,\"height\":1435},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Guidelines for Sterile Production According to EU GMP Annex 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry","description":"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/","og_locale":"en_US","og_type":"article","og_title":"New Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry","og_description":"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.","og_url":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-11-04T10:44:25+00:00","article_modified_time":"2024-11-04T11:01:32+00:00","og_image":[{"width":2560,"height":1435,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0"},"headline":"New Guidelines for Sterile Production According to EU GMP Annex 1","datePublished":"2024-11-04T10:44:25+00:00","dateModified":"2024-11-04T11:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/"},"wordCount":345,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg","articleSection":["GMP","Quality & Validation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/","url":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/","name":"New Guidelines for Sterile Production According to EU GMP Annex 1 - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg","datePublished":"2024-11-04T10:44:25+00:00","dateModified":"2024-11-04T11:01:32+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0"},"description":"Annex 1 introduces guidelines for equipment and systems in sterile manufacturing, focusing on the documentation and management of Critical Control Points (CCP) and Critical Process Parameters (CPP). Central to this is the evaluation of the impact of the system and rigorous risk management.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/11\/AdobeStock_938406468-scaled.jpeg","width":2560,"height":1435},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/gmp-en\/nuove-linee-guida-per-le-produzioni-sterili-secondo-leu-gmp-annex1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"New Guidelines for Sterile Production According to EU GMP Annex 1"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/64f06c0b8ba01c2f0f5d68f582ad16f0","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=21245"}],"version-history":[{"count":1,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21245\/revisions"}],"predecessor-version":[{"id":21246,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/21245\/revisions\/21246"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/21243"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=21245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=21245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=21245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}